Caption Management, LLC Nektar Therapeutics Call Options Transaction History

Caption Management, LLC

12 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2022 Aug 15, 2022	SELL	$3.17 - $6.17 $2.47 Million - $4.81 Million	-779,100 Reduced 87.2%	114,400 $435,000
Q1 2022 May 13, 2022	BUY	$4.16 - $13.72 $3.44 Million - $11.3 Million	825,800 Added 1219.79%	893,500 $4.82 Million
Q4 2021 Feb 11, 2022	SELL	$10.83 - $18.41 $46,569 - $79,163	-4,300 Reduced 5.97%	67,700 $916,000
Q3 2021 Nov 12, 2021	SELL	$13.07 - $18.84 $104,560 - $150,720	-8,000 Reduced 10.0%	72,000 $1.29 Million
Q2 2021 Aug 16, 2021	BUY	$16.52 - $20.4 $826,000 - $1.02 Million	50,000 Added 166.67%	80,000 $1.37 Million

Q1 2021 May 17, 2021	BUY	$16.56 - $25.46 $496,799 - $763,800	30,000 New	30,000 $600,000
Q4 2020 Feb 16, 2021	SELL	$15.77 - $19.03 $315,400 - $380,600	-20,000 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$16.59 - $24.79 $331,800 - $495,800	-20,000 Reduced 50.0%	20,000 $331,000
Q2 2020 Aug 14, 2020	BUY	$16.86 - $23.44 $118,020 - $164,080	7,000 Added 21.21%	40,000 $927,000
Q1 2020 May 15, 2020	SELL	$14.47 - $27.96 $101,290 - $195,720	-7,000 Reduced 17.5%	33,000 $588,000
Q4 2019 Feb 13, 2020	BUY	$15.87 - $23.12 $317,400 - $462,400	20,000 Added 100.0%	40,000 $864,000
Q3 2019 Nov 14, 2019	BUY	$16.91 - $36.27 $338,200 - $725,400	20,000 New	20,000 $365,000

128

111M

150K

Ticker NKTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,404,992
Market Cap $242M
Description
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Caption Management, LLC with notifications on news.